Teva Pharma

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced it has completed the sale of Plan B One-Step® and Teva’s value brands of emergency contraception to Foundation …

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced that five company-sponsored abstracts will be presented at the 2017 American College of Allergy, Asthma and Immunology (ACAAI) …

Maxim analysts Jason Kolbert and Jason Mccarthy weighed in today on the Israeli pharmaceutical giant Teva Pharmaceutical Industries Ltd (NYSE:TEVA), California based gene therapy company Avalanche Biotechnologies Inc (NASDAQ:AAVL), and gene therapy …

In a report issued August 5, Maxim Group analyst Jason Kolbert provided an optimistic view on Teva Pharmaceuticals (TEVA) following the release of the company’s second-quarter results, …

Maxim Group analyst Jason Kolbert today issued a note in which he reiterated a Buy rating on Momenta Pharma (MNTA) with a $17 price target. Momenta continues …